2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
55
Thoracic
6
Dermatologic
5
Head & Neck
3
Sarcoma
2
Gynecologic
2
Gastrointestinal
2
CNS
2
Breast
2
Other solid neoplasm
1
NET
1
Lymphoid
1
Endocrine
1
Conditions
Advanced Solid Tumors
483
Solid Tumor
446
Advanced Solid Tumor
414
Unspecified Adult Solid Tumor, Protocol Specific
362
Solid Tumors
336
Mesothelioma, Malignant
324
Mesothelioma
289
Solid Tumor, Adult
124
Carcinoma, Non-Small-Cell Lung
122
Retinoblastoma
117
Lung Neoplasms
77
Ovarian Neoplasms
75
Melanoma
65
Sarcoma
62
Carcinoma, Renal Cell
59
Stomach Neoplasms
58
Pancreatic Neoplasms
58
Neoplasms
53
Esophageal Neoplasms
53
Small Cell Lung Carcinoma
52
Colorectal Neoplasms
52
Hematopoietic and Lymphatic System Neoplasm
50
Uterine Cervical Neoplasms
46
Breast Neoplasms
46
Solid Tumours
35
Neoplasm Metastasis
35
Advanced or Metastatic Solid Tumors
35
Squamous Cell Carcinoma of Head and Neck
34
Carcinoma, Hepatocellular
32
Triple Negative Breast Neoplasms
31
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Clear-cell metastatic renal cell carcinoma
×
Other solid neoplasm
×
Clear all
NCT05698238
2023-03-15
CAMP1
Mabpro, a.s.
Phase 1
Not yet recruiting
50 enrolled